Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission

Schizophrenia Research

Volumn 116, Issue 1, 2010, Pages 9-15

  Bottlender, Ronald ^a,b   Strauß, Anton ^b   Möller, Hans Jürgen ^b  

^a EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Long term outcome; Recovery; Schizophrenia; Severe mental illness; Social disability

Indexed keywords

ADULT; AGE; APATHY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY ASSESSMENT SCHEDULE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL DISABILITY; SOCIAL INTERACTION;

ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOOD DISORDERS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL DESIRABILITY;

EID: 71549161744     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.10.008     Document Type: Article

References (29)

1. Angst, J., Stassen, H.H., Woggon, B. 1989. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology (Berlin) 99, 41-46.
2. Arbeitsgemeinschaft für Methodik und Diagnostik in der Psychiatrie (AMDP): Manual Zur Dokumentation Psychiatrischer Befunde. (Association for Methodology and Documentation in Psychiatry (AMDP): Manual for the documentation of psychiatric assessments). 2000. Göttingen; Bern; Toronto; Seattle : Hogrefe, Verl. für Psychologie.
3. Bearden C.E., Hoffman K.M., and Cannon T.D. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord. 3 3 (2001) 106-150
4. Bobon D., and Woggon B. The AMDP system in clinical psychopharmacology. Br. J. Psychiatry 148 (1986) 467-468
5. Bottlender R., Sato T., Groll C., Jäger M., Kunze I., and Möller H.J. Negative symptoms in depressed and schizophrenic patients: how do they differ?. J. Clin. Psychiatry 64 8 (2003) 954-958
6. Burns T., and Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta. Psychiatr. Scand. 116 6 (2007) 403-418
7. Faehndrich, E., Helmchen, H., Hippius, H., 1983. The history of the AMDP System. Mod. Probl. Pharmacopsychiatry 20, 10-18.
8. Frith C.D. The cognitive abnormalities underlying the symptomatology and the disability of patients with schizophrenia. Int. Clin. Psychopharmacol. 10 Suppl 3 (1995) 87-98
9. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 153 3 (1996) 321-330
10. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 26 1 (2000) 119-136
11. Jung, E., Krumm, B., Biehl, H., Maurer, K., Bauer-Schubart, C., 1989. Mannheimer Skala zur Einschätzung sozialer Behinhinderung, DAS-M. (Mannheim scale for the assessment of social disability.) Beltz Test GmbH, Weinheim; 1989.
12. Kuny, S., von Luckner, N., Baenninger, R., Bauer, P., Eichenberger, G., Woggon, B. 1983. Interrater reliability of AMDP and AMP symptoms. In: Bobon, D., Baumann, U., Angst, J., Helmchen, H., Hippius, H. (Eds.), AMDP-System in Pharmacopsychiatry. Karger, Basel, pp. 143-160.
13. Kurzban R., and Leary M.R. Evolutionary origins of stigmatization: the functions of social exclusion. Psychol. Bull. 127 2 (2001) 187-208
14. Leucht S., and Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39 5 (2006) 161-170
15. Marneros A., Deister A., and Rohde A. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr. Scand. 82 5 (1990) 352-358
16. Martinez-Aran A., Penades R., Vieta E., Colom F., Reinares M., Benabarre A., Salamero M., and Gasto C. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother. Psychosom. 71 1 (2002) 39-46
17. Martinez-Aran A., Vieta E., Colom F., Reinares M., Benabarre A., Torrent C., Goikolea J.M., Corbella B., Sanchez-Moreno J., and Salamero M. Neuropsychological performance in depressed and euthymic bipolar patients. Neuropsychobiology 46 Suppl 1 (2002) 16-21
18. Möller H.J., and Von Zerssen D. Der Verlauf schizophrener Psychosen unter den gegenwärtigen Behandlungsbedingungen. (The course of schizoophrenic psychoses under the current care conditions.) (1986), Springer-Verlag, Berlin
19. Möller H.J., Schmid-Bode W., Cording-Tommel C., Wittchen H.U., Zaudig M., and von Zerssen D. Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up. Acta Psychiatr. Scand. 77 4 (1988) 379-389
20. Möller H.-J., Bottlender R., Gross A., Hoff P., Wittmann J., Wegner U., and Strauss A. The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res. 56 1-2 (2002) 87-94
21. Mueser K.T., Bellack A.S., Morrison R.L., and Wixted J.T. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J. Psychiatr. Res. 24 1 (1990) 51-63
22. In: Murray C.J.L., and Lopez A.D. (Eds). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020 (1996), Harvard University Press
23. Pietzcker A., Gebhardt R., Strauss A., Stockel M., Langer C., and Freudenthal K. The syndrome scales in the AMDP-system. Mod. Probl. Pharmacopsychiatry 20 (1983) 88-99
24. Renfordt, E., Busch, H., von Cranach, M., Gulbinat, W., Tegeler, M., 1983. Particular aspects of the interrater reliability of the AMDP psychopathology scale. In: Bobon, D., Baumann, U., Angst, J., Helmchen, H., Hippius, H. (Eds.), AMDP-System in Pharmacopsychiatry. Karger, Basel, pp. 125-142.
25. Rymaszewska J., Jarosz-Nowak J., Kiejna A., Kallert T., Schützwohl M., Priebe S., Wright D., Nawka P., and Raboch J. Social disability in different mental disorders. Eur. Psychiatry. 22 3 (2007) 160-166
26. Sayce L. Stigma, discrimination and social exclusion: what's in a word?. Journal of Mental Health 7 4 (1998) 331-343(13)
27. Wiersma D., Wanderling J., Dragomirecka E., Ganev K., Harrison G., An Der Heiden W., Nienhuis F.J., and Walsh D. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol. Med. 30 5 (2000) 1155-1167
28. Woonings F.M., Appelo M.T., Kluiter H., Slooff C.J., and van den Bosch R.J. Learning (potential) and social functioning in schizophrenia. Schizophr. Res. 59 2-3 (2003) 287-296
29. Zarate Jr. C.A., Tohen M., Land M., and Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatr. Q. 71 4 (2000) 309-329